Nearly a third of medical device adverse events were not submitted to the FDA within a 30-day regulatory window, with most ...
Lilly has taken a non-exclusive license to deploy Dexcom’s CGM systems – which include app-based remote monitoring and alarm functions – in pen- and pump-based insulin systems that form the ...
5d
News-Medical.Net on MSNAutomated insulin delivery systems are safe and effective for older adults with type 1 diabetesNew research from Washington State University in collaboration with five other institutions suggests that automated insulin ...
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...
GlobalData on MSN18d
FDA clears Tandem’s Control-IQ+ technology for type 2 diabetesDuring the trial, both groups were monitored using the Dexcom G6 continuous glucose monitoring system ... Last September, Tandem's t:slim X2 insulin pump, which utilises Control-IQ technology, was ...
Insulet reported a higher-than-expected profit in the fourth quarter on Thursday, driven by strong demand for its wearable insulin pumps.
Both groups used a Dexcom G6 Continuous Glucose Monitoring (CGM ... The Company’s pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results